Advanced in Chromosome 13q Deletion

Takayuki Ueno

Tokyo, JP 
Advanced in Chromosome 13q Deletion
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Takayuki Ueno practices in Tokyo, Japan. Mr. Ueno is rated as an Advanced expert by MediFind in the treatment of Chromosome 13q Deletion. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Chromosome 13q Deletion, Mastectomy, and Salpingo-Oophorectomy.

His clinical research consists of co-authoring 127 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chromosome 13q Deletion.

Gender
Male

Locations

Tokyo, 1358550, Japan
Other Locations
Chiba, Japan
Ariake, 1358550, Japan
Kashiwa, Japan
Sendai, Japan
Chuo, 2608670, Japan
Kyotanabe, Japan
Mitaka, 1818611, Japan
Shinkawa, 1818611, Japan
Kyoto, Japan
Kawahara, 6068507, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy Plus Palbociclib Versus Hormonal Therapy Plus Placebo in Women With Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy Plus Palbociclib Versus Hormonal Therapy Plus Placebo in Women With Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
Enrollment Status: Completed
Publish Date: March 10, 2023
Intervention Type: Drug
Study Drugs: Palbociclib, Endocrine Therapy
Study Phase: Phase 3

127 Total Publications

Genetic and clinical characteristics of cranial nerve schwannoma harboring SH3PXD2A-HTRA1 fusion gene.
Genetic and clinical characteristics of cranial nerve schwannoma harboring SH3PXD2A-HTRA1 fusion gene.
Journal: Acta neuropathologica
Published: August 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ueno's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile